Premature heart disease; information is the key (1.27.00)
Alternative healthcare; separating hype from hope (2.17.00)
Women and heart disease (2.24.00)
Antioxidants and vitamin therapy (3.16.00)
Hormone therapy and heart health (3.23.00)
Internet healthcare information; caveats (4.13.00)
Coronary calcification in detection of heart disease (7.6.00)
Children and heart disease (9.14.00)
The Politics of Healthcare (11.5.00)
Diabetes and Heart Disease (11.9.00)
Symptoms of Heart Disease (2.1.01)
The Vice-president's Heart Condition (3.8.01)
Clinical Research and Ethics (60 Minutes Story) (4.9.01)
The New Cholesterol Guideline Implications (5.21.01)
Medicare Prescription Drug Benefit (7.20.01)
Implications of the Cerivastatin recall (8.13.01)
The COX-2 NSAID Cardiovascular Cautions (8.27.01)
Terrorism and Cardiovascular Disease (10.8.01)
Update on statins and antioxidants (12.17.01)
Appropriate use of generic drugs to control cost (4.22.02)
Implications of the Women's Health Initiative HRT data (7.15.02)
Inflammation and the development of heart disease (8.12.02)
Implications of ALLHAT and blood pressure treatment (12.23.02)
Implementation of Clinical Guidelines to Optimize Care (2.3.03)
The New Hypertension Guidelines (5.19.03)
The Polypill – good idea? (6.30.03)
New dietary study and role in cholesterol treatment (7.28.03)
Angioplasty preferred for acute coronary syndrome (8.24.03)
Dissecting aortic aneurysms (9.22.03)
Putting care back in health care (10.19.03)
Genes for healthy aging (10.20.03)
New HDL-cholesterol
therapy (11.10.03)
Obesity
in America (3.15.04)
Optimal
Cholesterol Levels (3.22.04)
Suboptimal
Treatment Plans (4.28.04)
Amended
Cholesterol Guidelines (7.19.04)
Coronary
Calcium Scanning Versus Stress Testing
(8.25.04)
Clinical
Trials, Drug Safety and the Vioxx
Recall (10.6.04)
Heart
Disease in Women - An Update (10.18.04)
Healthcare
and Politics - Part I of III: Overview
(10.13.04)
Healthcare
and Politics - Part II of III: Candidate
Positions (10.20.04)
Healthcare
and Politics - Part III of III: Elements
of a Solution (11.3.04)
Vitamin
E and Heart Disease (11.22.04)
NIH
Ethics and Unintended Consequences
(2.5.05 Letter in LA Times)
Payback
Time to Pharmaceutical Companies (2.6.05
Op-Ed)
The
Underutilization of Preventive Cardiovascular
Strategies in Women (2.11.05)
Cholesterol
Study Raises More Questions (3.14.05)
The
Loss of Dr. Darrell Davey (Letter
4.5.05)
Vitamins
for Heart Protection Come with Caveats
(9.26.05)
Medicare
Part D Prescription Drug Benefit (10.10.05)
The
Passing of Edward Masry (Commentary)
12.8.05
Lipitor
vs. Zocor (IDEAL Study) - Implications
for Patients (12.12.05)
Gender
Differences of Aspirin Effect (1.23.06)
The
ASTEROID Study - Reversing Coronary
Disease? (3.27.06)
Looking
Beyond the Drug Label - Letter in
The Washington Post (5.30.06)
Generic
Statins Brighten Medical Landscape
(7.17.06)
Risks
of Drug-coated Stents (9.11.06, republished
10.16.06)
Statins
Powerful Strategy to Increase Life
Span (11.6.06)
Views
on Failure of an HDL-raising drug
- full text (12.25.06)
Prevention
of Heart Disease Guidelines in Women
(3.5.07)
The
COURAGE Study - Angioplasty vs. Drug
Interventions Alone (4.2.07)
Hormone
Replacement Therapy Revisited (4.16.07)
Statin
Induced Low Cholesterol and Cancer
Risk (7.31.07)
Unexpected
Deaths in Young Athletes (11.12.07)
The
ENHANCE Trial - unedited column (edited
version 1.25.08)
Follow-up
Comments on the ENHANCE Trial
Perspectives
on Tim Russert's Death (6.22.08 Opinion
Page)
Smoke-free
Legislation Pays Health Benefits (8.10.08
Opinion Page)
Thumbnail
of Complexities of Obama vs. McCain
Healthcare (10.19.08 Opinion Page)
Statins
for "normal" cholesterol - the Jupiter
Trial (11.14.08)
A
truly American story (11.18.08 Letter
to Editor)
Aspirin
and Prevention of Cardiovascular Disease
(3.24.09)
Health
Care Reform - Basic Issues (8.23.09)
When
doctors were kings (?)...50 years
ago: response to a column (11.8.09)
Facts
to Consider and Clarify in Healthcare
Reform (11.15.09)
Healthcare
Reform - A Seminal Bill for America
(3.28.10)
Blood
Pressure Medications and Risk of Cancer
(6.27.10)
Statins:
Of Value in Healthy, High-risk Patients?
(7.11.10)
Repeal
Healthcare Reform - REALLY? (11.7.10)
Dissecting
Aortic Aneurysms - Equal Opportunity
Killer (12.26.10)
Congress
and Political Theater (1.23.11)
Sudden
Death in Young Athletes (3.20.11)
Liz
Taylor's Death Puts New Focus on Heart
Failure (3.24.11)
Uncertain
Role of Raising HDL-Cholesterol with
Niacin (6.5.11)
High
Dose Statins Draw FDA Warning (6.26.11)
Huge
Question in Coronary Care [Appropriateness
of PCI] (7.17.11)
The
Passing of Dr. Mark Starr (9.21.11)
Cholesterol
Testing in Children (11.20.11)
Your
Cardiovascular Destiny (2.5.12)
Red
Flags Raised on Red Meat (3.25.12)
Healthcare
Guidelines Require Caution (4.15.12)
The
Supreme Court and the Affordable Care
Act (7.1.12)
Deceptive
View of Ryan's Medicare Reform Proposal
(9.1.12)
Exercise
Caution in Using Nutrition Supplements
(10.14.12)
The
Unexpected Death of James Gandolfini
(6.23.13)
Obamacare
- End of the World or A New Beginning?
(9.30.13)
|
